CC
TMO icon

Cedar Capital’s Thermo Fisher Scientific TMO Stock Holding History

Cedar Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-8,595
Closed -$3.79M – 160
2020
Q3 		$3.79M Buy
8,595
+2,708
+46% +$1.12M 1.26% 24
2020
Q2 		$2.13M Buy
5,887
+202
+4% +$67.7K 0.82% 44
2020
Q1 		$1.61M Sell
5,685
-513
-8% -$162K 0.76% 38
2019
Q4 		$2.01M Buy
6,198
+1,223
+25% +$371K 0.93% 24
2019
Q3 		$1.45M Buy
4,975
+875
+21% +$251K 0.68% 42
2019
Q2 		$1.2M Sell
4,100
-149
-4% -$41K 0.51% 47
2019
Q1 		$1.16M Sell
4,249
-103
-2% -$25.6K 0.51% 48
2018
Q4 		$974K Sell
4,352
-997
-19% -$234K 0.49% 52
2018
Q3 		$1.31M Buy
5,349
+1,542
+41% +$355K 0.51% 47
2018
Q2 		$789K Buy
3,807
+1,050
+38% +$223K 0.35% 61
2018
Q1 		$569K Buy
2,757
+947
+52% +$199K 0.27% 69
2017
Q4 		$344K Buy
1,810
+429
+31% +$82.2K 0.17% 91
2017
Q3 		$261K Buy
1,381
+65
+5% +$11.8K 0.12% 96
2017
Q2 		$230K Buy
+1,316
New +$221K 0.1% 101
2016
Q4 		– Sell
-1,372
Closed -$218K – 100
2016
Q3 		$218K Sell
1,372
-293
-18% -$45.1K 0.08% 85
2016
Q2 		$246K Sell
1,665
-14
-0.8% -$2.07K 0.08% 73
2016
Q1 		$238K Sell
1,679
-178
-10% -$23.9K 0.07% 64
2015
Q4 		$263K Buy
+1,857
New +$248K 0.06% 63

Other funds holding TMO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cedar Capital's TMO Position: Q4 2020 in Review

Cedar Capital sold out of Thermo Fisher Scientific (TMO) in Q4 2020, closing a stake of 8,595 shares — an estimated $3.79M sold.

Cedar Capital first reported a position in TMO in Q4 2015 and held it in 18 quarters. The position peaked at $3.79M in Q3 2020. 2,030 funds tracked by Wall St. Rank hold TMO as of Q4 2020.

  • Cedar Capital reported no remaining Thermo Fisher Scientific position as of Q4 2020 after selling out during the quarter.
  • Cedar Capital sold 8,595 Thermo Fisher Scientific shares in Q4 2020, an estimated $3.79M.
  • Cedar Capital first reported a position in Thermo Fisher Scientific in Q4 2015 and held it in 18 quarters.
  • Cedar Capital's Thermo Fisher Scientific position peaked at $3.79M in Q3 2020.
  • 2,030 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2020.

Based on Cedar Capital's 13F filing for Q4 2020, filed 5 Feb 2021.